Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial-Reference-Cited by-同舟云学术

Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial

Published:2024-01 Issue: Volume:99 Page:104923
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Cullen Nicholas C.,Novak Petr^ORCID,Tosun Duygu^ORCID,Kovacech Branislav^ORCID,Hanes Jozef,Kontsekova Eva,Fresser Michal,Ropele Stefan,Feldman Howard H.,Schmidt Reinhold,Winblad Bengt,Zilka Norbert

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference19 articles.

1. First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model;Kontsekova;Alzheimers Res Ther,2014

2. ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease;Novak;Nat Aging,2021

3. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease;McKhann;Alzheimers Dement,2011

4. Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort;Tosun;Alzheimers Dement,2016

5. Alzheimer's disease neuroimaging I. Neuroimaging predictors of brain amyloidosis in mild cognitive impairment;Tosun;Ann Neurol,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging paradigms in Alzheimer's therapy;European Journal of Pharmacology;2024-10

2. Potential therapeutic natural compounds for the treatment of Alzheimer's disease;Phytomedicine;2024-09

3. Introduction to Alzheimer's Disease, Biomarkers, and the AI Revolution;Advances in Medical Technologies and Clinical Practice;2024-06-28

4. Current therapeutics for Alzheimer’s disease and clinical trials;Exploration of Neuroscience;2024-06-27

5. Novel Therapeutic Strategies in Alzheimer’s Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond;Journal of Clinical Medicine;2024-05-25